These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38413193)

  • 1. Mildly elevated pulmonary vascular resistance and worsened survival in PH-ILD: an opportunity for earlier diagnosis and intervention?
    Cassady SJ; Maron BA
    Thorax; 2024 Apr; 79(5):387-388. PubMed ID: 38413193
    [No Abstract]   [Full Text] [Related]  

  • 2. The Trouble With Group 3 Pulmonary Hypertension in Interstitial Lung Disease: Dilemmas in Diagnosis and the Conundrum of Treatment.
    King CS; Shlobin OA
    Chest; 2020 Oct; 158(4):1651-1664. PubMed ID: 32387520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial lung disease-associated pulmonary hypertension - what the future holds.
    Cottin V; Diesler R; Turquier S; Valenzuela C
    Curr Opin Pulm Med; 2023 Sep; 29(5):406-415. PubMed ID: 37417835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension.
    Mismetti V; Delavenne X; Montani D; Bezzeghoud S; Delezay O; Hodin S; Launay D; Marchand-Adam S; Nunes H; Ollier E; Reynaud-Gaubert M; Pastre J; Traclet J; Quetant S; Zeghmar S; Bertoletti L; Cottin V
    Respir Res; 2023 Nov; 24(1):273. PubMed ID: 37936223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.
    Yuan YP; Yuan P; Su YL; Jiang R; Zhang R; He J; Qiu HL; Luo CJ; Liu JM; Gong SG; Wang L; Zhao QH
    Clin Rheumatol; 2022 Jun; 41(6):1675-1686. PubMed ID: 35099674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary Vascular and Right Ventricular Burden During Exercise in Interstitial Lung Disease.
    Oliveira RKF; Waxman AB; Hoover PJ; Dellaripa PF; Systrom DM
    Chest; 2020 Jul; 158(1):350-358. PubMed ID: 32173491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
    Mathai SC; Hummers LK; Champion HC; Wigley FM; Zaiman A; Hassoun PM; Girgis RE
    Arthritis Rheum; 2009 Feb; 60(2):569-77. PubMed ID: 19180517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up.
    Vilela VS; Dias MM; Salgado ÂA; da Silva BRA; Lopes AJ; Bessa EJC; Bruno LP; da Costa CH; Levy RA; Rufino R
    BMC Pulm Med; 2021 Jul; 21(1):251. PubMed ID: 34325685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild elevation of pulmonary vascular resistance predicts mortality regardless of mean pulmonary artery pressure in mild interstitial lung disease.
    Sato T; Furukawa T; Teramachi R; Fukihara J; Yamano Y; Yokoyama T; Matsuda T; Kataoka K; Kimura T; Sakamoto K; Ishii M; Kondoh Y
    Thorax; 2024 Apr; 79(5):422-429. PubMed ID: 38316550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
    Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
    Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and hemodynamic characteristics of pulmonary hypertension associated with interstitial lung disease in China.
    Wang L; Zhao QH; Pudasaini B; Jiang R; Gong SG; He J; Yuan P; Liu JM
    Clin Respir J; 2018 Mar; 12(3):915-921. PubMed ID: 28026153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary vascular resistance estimated by Doppler echocardiography predicts mortality in patients with interstitial lung disease.
    Yasui K; Yuda S; Abe K; Muranaka A; Otsuka M; Ohnishi H; Hashimoto A; Takahashi H; Tsuchihashi K; Takahashi H; Takahashi S; Miura T
    J Cardiol; 2016 Oct; 68(4):300-7. PubMed ID: 27032318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
    Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
    J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical assessment for pulmonary hypertension in interstitial lung disease.
    Chan RK; Horrigan M; Goh NSL; Khor YH
    Intern Med J; 2023 Aug; 53(8):1415-1422. PubMed ID: 35848362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the management of pulmonary hypertension with interstitial lung disease.
    Waxman AB; Elia D; Adir Y; Humbert M; Harari S
    Eur Respir Rev; 2022 Sep; 31(165):. PubMed ID: 35831007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study.
    Rahaghi FF; Kolaitis NA; Adegunsoye A; de Andrade JA; Flaherty KR; Lancaster LH; Lee JS; Levine DJ; Preston IR; Safdar Z; Saggar R; Sahay S; Scholand MB; Shlobin OA; Zisman DA; Nathan SD
    Chest; 2022 Jul; 162(1):145-155. PubMed ID: 35176276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interstitial lung diseases and pulmonary hypertension].
    Hauber HP
    Internist (Berl); 2009 Sep; 50(9):1072, 1074-6, 1078-9. PubMed ID: 19575171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival: A Large Cohort Study of the German Network for Systemic Sclerosis.
    Moinzadeh P; Bonella F; Oberste M; Weliwitage J; Blank N; Riemekasten G; Müller-Ladner U; Henes J; Siegert E; Günther C; Kötter I; Pfeiffer C; Schmalzing M; Zeidler G; Korsten P; Susok L; Juche A; Worm M; Jandova I; Ehrchen J; Sunderkötter C; Keyßer G; Ramming A; Schmeiser T; Kreuter A; Lorenz HM; Hunzelmann N; Kreuter M
    Chest; 2024 Jan; 165(1):132-145. PubMed ID: 37582424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension in interstitial lung disease.
    Nathan SD
    Int J Clin Pract Suppl; 2008 Jul; (160):21-8. PubMed ID: 18720579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.